| Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2093630 | TAF1D | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 11 | - |
PV=1 FDR=1 FC=0.015 |
|
| 2093631 | TAF1D | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 11 | - |
PV=1 FDR=1 FC=-0.003 |
|
| 2093632 | TAF1D | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 11 | - |
PV=0.096 FDR=1 FC=-0.037 |
|
| 2093633 | HTT | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 4 | - |
PV=1 FDR=1 FC=0.045 |
